CHAPEL HILL, N.C., Nov. 2 /PRNewswire/ -- Any drugs' success in the market hinges on effective branding, but how do companies design branding teams to accomplish this? How do they structure their branding teams, who do they include, and what activities and procedures do they use to drive sales of their products once they hit the market and beyond?
Best Practices latest study, "Designing Effective Brand Teams: Structure, Governance, Performance and Operations" provides benchmarks, strategies, and insights from leading pharmaceutical and biotechnology companies for building brand teams that properly support the growth of their products in the market. According to Chris Bogan, CEO of Best Practices, LLC, "Building a winning brand team is like building a World Series Champion team. You need a strong core team, with Bench Strength in areas critical to your success."
To download a 17-page complimentary copy of this study, click on the following or paste it into your browser: http://www3.best-in-class.com/dr284.htm
-- Most brands recognize a core team of three to 10 people, usually
concentrated around the marketing function, who handle tactical matters
and "organic problem solving".
-- Other members of the core team are drawn most commonly from Medical
Affairs, Strategy, Managed Care, and Clinical areas.
-- Extended teams, usually made up of six to 22 members, augment
representation from core team membership and add other critical areas:
Sales, Market Research, Regulatory, Product Development, Manufacturing
and Supply Chain, Safety, Customer Service, etc.
Companies that participated in this study include: Abbott; Bayer
Schering AG; Cephalon; Merial; Inc.; Orchid; Alcon Laboratories; Eli Lilly;
Amylin; Genentech; Baxter Healthcare; GlaxoSmithKline; Bayer; Johnson &
Johnson; Biogen Idec; Novartis; Novo Nordisk; P
|SOURCE Best Practices, LLC|
Copyright©2007 PR Newswire.
All rights reserved